renal cell carcinoma

You have access
Site-specific Response to Nivolumab in Renal Cell Carcinoma
TAKAHITO NEGISHI, NOBUKI FURUBAYASHI, TOHRU NAKAGAWA, NAOTAKA NISHIYAMA, HIROSHI KITAMURA, YOSHIFUMI HORI, KENTAROU KUROIWA, YUHYON SON, NARIHITO SEKI, TOSHIHISA TOMODA, EIJIRO OKAJIMA and MOTONOBU NAKAMURA

Anticancer Research March 2021, 41 (3) 1539-1545; DOI: https://doi.org/10.21873/anticanres.14913
You have access
Challenging Cases of Renal Cell Cancers With or Without Tumor Thrombus During the Covid-19 Pandemic
GAETANO CIANCIO, AHMED FARAG and JEFFREY J. GAYNOR

Anticancer Research January 2021, 41 (1) 335-340; DOI: https://doi.org/10.21873/anticanres.14780
You have access
Stereotactic Radiotherapy for the Treatment of Patients With Oligo-progressive Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor: Data From the Real World
VITTORIO GEBBIA, ANDREA GIRLANDO, ALFIO DI GRAZIA, IVAN FAZIO, NICOLÒ BORSELLINO, DARIO PIAZZA, VINCENZO SERRETTA, STEFANO PERGOLIZZI, ANTONIO PONTORIERO, ALBERTO FIRENZE and MARIA ROSARIA VALERIO

Anticancer Research December 2020, 40 (12) 7037-7043; DOI: https://doi.org/10.21873/anticanres.14730
You have access
Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma
TAKAYUKI SUGIYAMA, SEIICIRO OZONO and HIDEAKI MIYAKE

Anticancer Research November 2020, 40 (11) 6337-6343; DOI: https://doi.org/10.21873/anticanres.14654
You have access
Expression Analysis of Tyrosine Phosphatase Genes at Different Stages of Renal Cell Carcinoma
IZABELA LACZMANSKA, LUKASZ LACZMANSKI and MARIA M. SASIADEK

Anticancer Research October 2020, 40 (10) 5667-5671; DOI: https://doi.org/10.21873/anticanres.14580
You have access
Radical Nephrectomy and Pulmonary Lobectomy for Renal Cell Carcinoma With Tumor Thrombus Extension into the Inferior Vena Cava and Pulmonary Arteries
AYSSWARYA MANOHARAN, ALEJANDRO LUGO-BARUQUI and GAETANO CIANCIO

Anticancer Research October 2020, 40 (10) 5837-5844; DOI: https://doi.org/10.21873/anticanres.14602
You have access
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma
TAIGO KATO, EISUKE TOMIYAMA, YOKO KOH, MAKOTO MATSUSHITA, YUJIRO HAYASHI, KOSUKE NAKANO, YU ISHIZUYA, CONG WANG, KOJI HATANO, ATSUNARI KAWASHIMA, TAKESHI UJIKE, KEISUKE KAWASAKI, EIICHI MORII, KUNIHITO GOTOH, HIDETOSHI EGUCHI, KAZUMA KIYOTANI, KAZUTOSHI FUJITA, NORIO NONOMURA and MOTOHIDE UEMURA

Anticancer Research September 2020, 40 (9) 4875-4883; DOI: https://doi.org/10.21873/anticanres.14490
You have access
The Impact of Hypertension on the Clinicopathological Outcome and Progression of Renal Cell Carcinoma
TOMOYUKI MAKINO, KOUJI IZUMI, HIROAKI IWAMOTO, SUGURU KADOMOTO, RENATO NAITO, HIROSHI YAEGASHI, KAZUYOSHI SHIGEHARA, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research July 2020, 40 (7) 4087-4093; DOI: https://doi.org/10.21873/anticanres.14407
You have access
Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma
ALEXANDER COX, CHENMING ZHAO, YURI TOLKACH, DANIEL NETTERSHEIM, DORIS SCHMIDT, GLEN KRISTIANSEN, STEFAN C. MUELLER, MANUEL RITTER, STEFAN HAUSER and JOERG ELLINGER

Anticancer Research June 2020, 40 (6) 3119-3128; DOI: https://doi.org/10.21873/anticanres.14293
You have access
Clinicopathological Significance of MTUS1 Expression in Patients With Renal Cell Carcinoma
JONGMIN SIM, YOUNG CHAN WI, HA YOUNG PARK, SUNG YUL PARK, YOUNG EUN YOON, SEONGSIK BANG, YESEUL KIM, KISEOK JANG, SEONG SAM PAIK and SU-JIN SHIN

Anticancer Research May 2020, 40 (5) 2961-2967; DOI: https://doi.org/10.21873/anticanres.14275

Main menu

User menu

Search

renal cell carcinoma

Pages